MicroVision Price Target Maintained With a $3.00/Share by Cantor Fitzgerald

MicroVision Price Target Maintained With a $3.00/Share by Cantor Fitzgerald

Dow JonesJul 2 00:08

Cantor Fitzgerald Reiterates Neutral on Microvision, Maintains $3 Price Target

Cantor Fitzgerald analyst Andres Sheppard reiterates Microvision (NASDAQ:MVIS) with a Neutral and maintains $3 price target.

BenzingaJul 1 23:58

Microvision Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 194.12% Cantor Fitzgerald $3 → $3 Reiterates Neutral → Neutral 03/01/2024 194.12% Cantor Fitzge

BenzingaJul 1 23:57

"Lead Big Brother" manipulating the market? Regulators: lack of evidence, prosecution is unfounded.

Did the leader use their personal influence to manipulate the stock price of meme, and then profit greatly from it? Would this be considered market manipulation? If the SEC wants to prosecute them for market manipulation, they need evidence that the leader deceived investors to some extent, but currently the SEC lacks such evidence.

wallstreetcnJun 7 16:06

MicroVision Management to Participate in Deutsche Bank's Global Auto Industry Conference on June 11 and 12, 2024

REDMOND, WA / ACCESSWIRE / June 3, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced that management will participate in D

AccesswireJun 3 21:20

MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship

SINGAPORE, May 23, 2024 /PRNewswire/ -- MediThinQ, the Korean startup pioneering extended reality (XR) wearable displays for surgical applications, unveils its groundbreaking SCOPEYE 3D Micro Surgery

PR NewswireMay 23 16:00